Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion type Assertion NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_head.
- NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion description "[results suggest that conventional follicular thyroid carcinomas develop through at least two distinct molecular pathways initiated by either RAS point mutation or PAX8-peroxisome proliferator-activated receptor gamma rearrangement]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_provenance.
- NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion evidence source_evidence_literature NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_provenance.
- NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion SIO_000772 12727991 NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_provenance.
- NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion wasDerivedFrom lhgdn-20090331 NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_provenance.
- NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_assertion wasGeneratedBy ECO_0000203 NP164045.RARQL1dlP2zjox1rcSif0Ik8jmHi8kYJd_p4qFGNdLdkQ130_provenance.